4//SEC Filing
NORDMANN RONALD M 4
Accession 0000878088-12-000028
CIK 0000878088other
Filed
Mar 20, 8:00 PM ET
Accepted
Mar 21, 5:42 PM ET
Size
20.1 KB
Accession
0000878088-12-000028
Insider Transaction Report
Form 4
NORDMANN RONALD M
Director
Transactions
- Sale
Common Stock
2012-03-19$37.06/sh−304$11,266→ 4,536 total - Sale
Common Stock
2012-03-19$37.04/sh−1,803$66,783→ 6,043 total - Sale
Common Stock
2012-03-19$37.02/sh−507$18,769→ 8,053 total - Sale
Common Stock
2012-03-19$37.03/sh−207$7,665→ 7,846 total - Exercise/Conversion
Common Stock
2012-03-19$28.79/sh+7,500$215,925→ 11,500 total - Sale
Common Stock
2012-03-19$37.08/sh−136$5,043→ 4,100 total - Sale
Common Stock
2012-03-19$37.05/sh−1,203$44,571→ 4,840 total - Sale
Common Stock
2012-03-19$37.07/sh−300$11,121→ 4,236 total - Exercise/Conversion
Common Stock, Option to Buy
2012-03-19−7,500→ 0 totalExercise: $28.79From: 2003-06-12Exp: 2012-06-11→ Common Stock (7,500 underlying) - Sale
Common Stock
2012-03-19$37.01/sh−2,940$108,815→ 8,560 total - Sale
Common Stock
2012-03-19$37.09/sh−100$3,709→ 4,000 total
Footnotes (1)
- [F1]Mr. Nordmann was granted an option to purchase 7,500 shares of Common Stock under the Company's 1997 Directors Stock and Deferred Fee Plan on June 12, 2002, all of which vested on June 12, 2003. The expiration date of this option is June 11, 2012.
Documents
Issuer
PAR PHARMACEUTICAL COMPANIES, INC.
CIK 0000878088
Entity typeother
Related Parties
1- filerCIK 0001189790
Filing Metadata
- Form type
- 4
- Filed
- Mar 20, 8:00 PM ET
- Accepted
- Mar 21, 5:42 PM ET
- Size
- 20.1 KB